Intrapace

About Intrapace

IntraPace has developed the abiliti® system, an implantable device for the treatment of obesity. The system uses a closed-loop gastric stimulation technology to help patients manage their weight. The device is implanted in the patient's abdomen and sends electrical pulses to the stomach, which helps to control hunger and create a feeling of fullness.

The abiliti® system also includes a patient-directed tool that allows individuals to track their food intake and physical activity. This data is then transmitted to the physician, who can monitor the patient's progress and provide guidance. The business model is based on the sale of this medical device to healthcare providers and patients.

The company targets individuals who are struggling with obesity and are looking for an alternative to traditional weight loss surgeries. The market for obesity treatment is large and growing, and IntraPace aims to capture a share of this market with its less-invasive solution. The company has received CE Mark certification in Europe, which allows for the commercialization of the abiliti® system in the European Union.